Free shipping on all orders over $ 500

CCR7 Ligand 1

Cat. No. M40607
CCR7 Ligand 1 Structure
Synonym:

CCR7-Cmp2105

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CCR7 Ligand 1 (CCR7-Cmp2105) is a human CC chemokine receptor 7 (CCR7) variant ligand and a potent intracellular CCR7 receptor variant antagonist with a Kd value of 3 nM. In addition, CCR7 Ligand 1 also inhibited CCL19 activation with an IC50 value of 7.3 μM.

Chemical Information
Molecular Weight 475.56
Formula C22H29N5O5S
CAS Number 681514-83-0
Form Solid
Solubility (25°C) DMSO 100 mg/mL
Storage -20°C
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Ming Xiang et al. Pharmacol Res. Kinsenoside attenuates liver fibro-inflammation by suppressing dendritic cells via the PI3K-AKT-FoxO1 pathway

[2] Mauro Di Pilato et al. Cell. CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment

[3] Hiroyuki Tsuchiya et al. Regen Ther. Immune evasion by cancer stem cells

[4] Anwar Salem et al. Biochim Biophys Acta Rev Cancer. CCR7 as a therapeutic target in Cancer

[5] B Szekely et al. Ann Oncol. Immunological differences between primary and metastatic breast cancer

Related CCR Products
CCR6 antagonist 1

CCR6 antagonist 1 is a CCR6 antagonist that inhibits the CCL20/CCR6 axis. CCR6 antagonist 1 can be used in the research of autoimmune-mediated inflammatory diseases, such as inflammatory bowel diseases (IBDs).

IPG7236

IPG7236 is a selective CCR8 antagonist that also exhibits significant tumor suppression in a mouse xenograft model of human breast cancer.IPG7236 can be used in cancer-related studies.

CKLF1-C19

CKLF1-C19 is the C-terminal peptide of human chemokine-like factor 1 (CKLF1).

Met-RANTES (human)

Met-RANTES (human) is a partial antagonist of CCR5.

IPG0521

IPG0521 is a bifunctional antibody targeting CCR8, which can block CCR8 signaling with high intensity and weak ADCC function, and can effectively inhibit the growth of multiple tumor types in homologous and immunohumanized mouse models.

  Catalog
Abmole Inhibitor Catalog




Keywords: CCR7 Ligand 1, CCR7-Cmp2105 supplier, CCR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.